Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> MutationRichard M. Stone, Hartmut Döhner, Susan M. Geyer et al.|New England Journal of Medicine|2017Cited by 2.2k
Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysisRahma Warsame, Angela Dispenzieri, Betsy LaPlant et al.|Blood Cancer Journal|2020Cited by 25